📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Application of a High-Content Screening Assay Utilizing Primary Human Lung Fibroblasts to Identify Antifibrotic Drugs for Rapid Repurposing in COVID-19 Patients. (2021)

First Author: Marwick JA
Attributed to:  MICA: A new paradigm for testing pathway tractability in lung disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/24725552211019405

PubMed Identifier: 34078171

Publication URI: http://europepmc.org/abstract/MED/34078171

Type: Journal Article/Review

Volume: 26

Parent Publication: SLAS discovery : advancing life sciences R & D

Issue: 9

ISSN: 2472-5552